ArticlePharmaceutics2026
Engineered Polylactic Acid (PLA) Microcapsules for Spatiotemporally Coupled Delivery and Synergistically Enhanced Dual Immunity.
Shaoyu Guan, Yu Zhang, Hongyi Liu, Jialu Li, Lisha Wang, Jing Wang, Hua Yue, Fenghua Xu
Abstract read
In one paragraphArticle in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Shaoyu GuanPharmaceutical Sciences Research Division, Department of Pharmacy, Medical Supplies Centre of PLA General Hospital, Medical School of Chinese PLA, Beijing 100853, China.ORCID 0009-0003-7192-6302 Yu ZhangState Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China.
Hongyi LiuState Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China.
Jialu LiPharmaceutical Sciences Research Division, Department of Pharmacy, Medical Supplies Centre of PLA General Hospital, Medical School of Chinese PLA, Beijing 100853, China.
Lisha WangPharmaceutical Sciences Research Division, Department of Pharmacy, Medical Supplies Centre of PLA General Hospital, Medical School of Chinese PLA, Beijing 100853, China.
Jing WangState Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China.
Hua YueState Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China.ORCID 0000-0003-2621-8326 Fenghua XuPharmaceutical Sciences Research Division, Department of Pharmacy, Medical Supplies Centre of PLA General Hospital, Medical School of Chinese PLA, Beijing 100853, China.
Funding
National Key Research and Development Program of China 2021YFC2302600National Key Research and Development Program of China 2023YFC2307701National Natural Science Foundation of China 82171814National Natural Science Foundation of China U25A20654
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
composite adjuvantdelivery systemdual immunityPLA microcapsules
Identifiers
PMID42076108
PMCPMC13118379
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390